Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

In addition to Wegovy, incretin mimetics FDA-approved for ... Research and Manufacturers of America, condemned the ad for misleading consumers about the safety and effectiveness of the compounded ...